FdaApplication

ANDA 206133

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHIKMA PHARMS
application_typeANDA
approval_date2018-04-12

Products (4)

ProductActive ingredientStrengthDosage form
EVEROLIMUSEVEROLIMUS0.25MGTABLET;ORAL
EVEROLIMUSEVEROLIMUS0.75MGTABLET;ORAL
EVEROLIMUSEVEROLIMUS0.5MGTABLET;ORAL
EVEROLIMUSEVEROLIMUS1MGTABLET;ORAL

4 products